Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

TGK-2 reported for 3 months of 2025 by RAS

4/30/25 TGKB

FGC-Rosseti reported for 3 months of 2025 by RAS

4/30/25 FEES

“Nornickel reports for 3 months of 2025 by RAS

4/30/25 GMKN

Gazprom reports for 2024 by IFRS

4/30/25 GAZP

Aeroflot reported for 3 months of 2025 by RAS

4/30/25 AFLT

SFI reported for 3 months of 2025 by RAS

4/30/25 SFIN

Varioganneftegaz reported for 2024 by RAS

4/30/25 VJGZ

Varioganneftegaz reported for 2024 by IFRS

4/30/25 VJGZ

VSMPO-AVISMA reported for 2024 by IFRS

4/30/25 VSMO

Rosseti Moscow Region reported for 3 months of 2025 by RAS

4/30/25 MSRS